WHO ICTRP trial
A 12-week, randomised, double-blind, placebo-controlled study to assess the…
EUCTR2007-004033-42-LV · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2007-004033-42-LV |
|---|---|
| Public title | A 12-week, randomised, double-blind, placebo-controlled study to assess the anti-inflammatory activity, efficacy and safety of GW856553 in subjects with chronic obstructive pulmonary disease (COPD). |
| Scientific title | A 12-week, randomised, double-blind, placebo-controlled study to assess the anti-inflammatory activity, efficacy and safety of GW856553 in subjects with chronic obstructive pulmonary disease (COPD). |
| Primary sponsor | GlaxoSmithKline Research and Development Ltd |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Finland;United Kingdom;Germany;Netherlands;Slovenia;Estonia;Latvia;Lithuania |
| Conditions | Chronic obstructive pulmonary disease MedDRA version: 9.1 Level: LLT Classification code 10009033 Term: Chronic obstructive pulmonary disease |
| Interventions | Product Code: GW856553 Pharmaceutical Form: Tablet Pharmaceutical form of the placebo: Tablet Route of administration of the placebo: Oral use Trade Name: Seretide Pharmaceutical Form: Inhalation powder, pre-dispensed Pharmaceutical form of… |
| Registration date | Oct 18, 2007 |
| Target size | 740 |
| Secondary IDs | MKI102428 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: